Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
出版年份 2021 全文链接
标题
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
作者
关键词
Coronavirus disease 2019, Covid-19, Diabetes, GLP-1RA, Anti-diabetic
出版物
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 179, Issue -, Pages 109031
出版商
Elsevier BV
发表日期
2021-08-29
DOI
10.1016/j.diabres.2021.109031
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
- (2021) Chioma Izzi-Engbeaya et al. BMJ Open Diabetes Research & Care
- Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
- (2021) Simone Bastrup Israelsen et al. DIABETES OBESITY & METABOLISM
- Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO study
- (2021) Matthieu Wargny et al. DIABETOLOGIA
- Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression
- (2021) Timotius Ivan Hariyanto et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID‐19): A systematic review and meta‐analysis
- (2021) Timotius Ivan Hariyanto et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Parkinson’s disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A Systematic Review, Meta-Analysis, and Meta-Regression
- (2021) Cynthia Putri et al. PARKINSONISM & RELATED DISORDERS
- Human immunodeficiency virus and mortality from coronavirus disease 2019: A systematic review and meta-analysis
- (2021) Timotius I. Hariyanto et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis
- (2021) Timotius Ivan Hariyanto et al. SLEEP MEDICINE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
- (2020) Daniel J Drucker ENDOCRINE REVIEWS
- Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
- (2020) Maria Mirabelli et al. International Journal of Environmental Research and Public Health
- Letter to the Editor: Comment on GLP-1-based drugs and COVID-19 treatment
- (2020) Tianru Jin et al. Acta Pharmaceutica Sinica B
- Diabetes increases the mortality of patients with COVID-19: a meta-analysis
- (2020) Zeng-hong Wu et al. ACTA DIABETOLOGICA
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
- (2020) Vincenzo M. Monda et al. Diabetes Therapy
- Are diabetes and its medications risk factors for the development of COVID-19? Data from a population-based study in Sicily
- (2020) Silverii Giovanni Antonio et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Diabetes, infection risk and COVID-19
- (2020) Suheda Erener Molecular Metabolism
- COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
- (2020) Harald Sourij et al. DIABETES OBESITY & METABOLISM
- Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection
- (2020) Timotius Ivan Hariyanto et al. JOURNAL OF MEDICAL VIROLOGY
- Obesity in patients with COVID-19: a systematic review and meta-analysis
- (2020) Yi Huang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Long-term observational study on the impact of GLP-1R agonists on lung function in diabetic patients
- (2019) Paola Rogliani et al. RESPIRATORY MEDICINE
- A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials
- (2018) Vanita R. Aroda DIABETES OBESITY & METABOLISM
- Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
- (2018) Shinji Toki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
- (2018) Li Zhao et al. Frontiers in Endocrinology
- Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice
- (2016) Feng Zhou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial
- (2016) A Blackman et al. INTERNATIONAL JOURNAL OF OBESITY
- Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
- (2016) Young-Sun Lee et al. MEDIATORS OF INFLAMMATION
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- Glucagon Like Peptide-1 (GLP-1) Modulates OVA-Induced Airway Inflammation and Mucus Secretion Involving a Protein Kinase A (PKA)-Dependent Nuclear Factor-κB (NF-κB) Signaling Pathway in Mice
- (2015) Tao Zhu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle–Ottawa Scale and the RTI item bank
- (2014) Andrea V Margulis et al. Clinical Epidemiology
- Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice
- (2013) Niels-Erik Viby et al. ENDOCRINOLOGY
- GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats
- (2010) Hui-Chun Ku et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started